Search Results - Botha, M.
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
-
5
-
6
Final Results of the Randomized Phase II NorCap-CA223 Trial Comparing First-Line All-Oral Versus Taxane-Based Chemotherapy for HER2-Negative Metastatic Breast Cancer by Cinieri, S., Chan, Arlene, Altundag, K., Vandebroek, A., Tubiana-Mathieu, N., Barnadas, A., Dodyk, P., Lazzarelli, S., Botha, M., Rauch, D., Villanova, G., Coskun, U.
Published 2017Get full text